Trademark/Service Mark Application, Principal Register
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
The color(s) magenta is/are claimed as a feature of the mark.
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of the word NARCAN in stylized font in the color magenta.
PIXEL COUNT ACCEPTABLE
YES
PIXEL COUNT
640 x 828
REGISTER
Principal
APPLICANT INFORMATION
*OWNER OF MARK
Adapt Pharma Operations Limited
INTERNAL ADDRESS
6th Floor
*MAILING ADDRESS
6 Earlsfort Terrace
*CITY
Dublin 2
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
Ireland
*EMAIL ADDRESS
officeactionstm@brinksgilson.com
LEGAL ENTITY INFORMATION
TYPE
limited liability company
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED
Ireland
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS
005
*IDENTIFICATION
Pharmaceutical preparations, namely, opioid antagonists and narcotic antagonists; pharmaceutical and drug preparations for use in treatment of
opiate, opioid or narcotic overdose
Auto-injectors, syringes, intranasal drug delivery devices, spray pump devices for nasal delivery, and devices for nasal delivery, all
pre-filled with pharmaceuticals, namely, opioid antagonists and narcotic antagonists and pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; nasal spray
preparations
FILING BASIS
SECTION 1(b)
INTERNATIONAL CLASS
044
*IDENTIFICATION
Medical and health information services; providing a website for patients, medical professionals, and pharmacists featuring information in the
fields of health, medicine, opioids and narcotics, opioid antagonists and narcotic antagonists, drug overdoses, and emergency medical tips; providing a website featuring pharmaceutical drug
information relating to diagnostic, prophylactic and therapeutic properties of naloxone, opioid antagonists and narcotic antagonists
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)
Trademark/Service Mark Application, Principal Register
Serial Number:88863747
Filing Date:04/08/020
To the Commissioner for Trademarks:
MARK: NARCAN (stylized and/or with design, see mark)
The literal element of the mark consists of NARCAN. The color(s) magenta is/are claimed as a feature of the mark. The mark consists of the word NARCAN in stylized font in the color magenta.
The applicant, Adapt Pharma Operations Limited, a limited liability company legally organized under the laws of Ireland, having an address of
6th Floor
6 Earlsfort Terrace
Dublin 2
Ireland
officeactionstm@brinksgilson.com
requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C.
Section 1051 et seq.), as amended, for the following:
International Class 005: Pharmaceutical preparations, namely, opioid antagonists and narcotic antagonists; pharmaceutical and drug preparations for use in treatment of opiate, opioid or
narcotic overdose
In International Class 005, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 02/00/2016, and first used in
commerce at least as early as 02/00/2016, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any
item in the class of listed goods/services, consisting of a(n) photograph of the goods and packaging. Specimen File1
International Class 005: Auto-injectors, syringes, intranasal drug delivery devices, spray pump devices for nasal delivery, and devices for nasal delivery, all pre-filled with pharmaceuticals,
namely, opioid antagonists and narcotic antagonists and pharmaceutical and drug preparations for use in treatment of opiate, opioid or narcotic overdose; nasal spray preparations
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.
International Class 044: Medical and health information services; providing a website for patients, medical professionals, and pharmacists featuring information in the fields of health,
medicine, opioids and narcotics, opioid antagonists and narcotic antagonists, drug overdoses, and emergency medical tips; providing a website featuring pharmaceutical drug information relating to
diagnostic, prophylactic and therapeutic properties of naloxone, opioid antagonists and narcotic antagonists
In International Class 044, the mark was first used by the applicant or the applicant's related company or licensee or predecessor in interest at least as early as 02/01/2016, and first used in
commerce at least as early as 02/01/2016, and is now in use in such commerce. The applicant is submitting one(or more) specimen(s) showing the mark as used in commerce on or in connection with any
item in the class of listed goods/services, consisting of a(n) page from website.
Claim of Active Prior Registration(s)
The applicant claims ownership of active prior U.S. Registration Number(s) 0808366 and 5160883.
The owner's/holder's proposed attorney information: Virginia Wolk Marino. Other appointed attorneys are Jeffery A. Handelman, David S. Fleming, Howard S. Michael, Andrew J. Avsec, Jennifer Theis,
Emily T. Kappers and Fan Cheng. Virginia Wolk Marino of Brinks Gilson & Lione, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located
at
P. O. Box 10395
Chicago, Illinois 60610
United States
312-321-4200(phone)
312-321-4299(fax)
officeactions@brinksgilson.com
The docket/reference number is 16622/358.
Virginia Wolk Marino submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any
U.S. Commonwealth or territory.
The applicant's current Correspondence Information:
Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed,
and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).
Declaration
Declaration Signature
Signature: /Jennifer L Fox/ Date: 04/08/2020
Signatory's Name: Jennifer L. Fox
Signatory's Position: SVP Legal Affairs and Deputy General Counsel
Payment Sale Number: 88863747
Payment Accounting Date: 04/08/2020
Serial Number: 88863747
Internet Transmission Date: Wed Apr 08 10:31:06 ET 2020
TEAS Stamp: USPTO/BAS-XX.XX.XXX.XXX-2020040810310620
8737-88863747-710a786b1375664b61b3716bff
2f5dd472cb7eb762bf759c9fa873ef925b3618a5
d-DA-31061798-20200326111126916668